465 related articles for article (PubMed ID: 16987882)
1. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
Talbot K; Ansorge O
Hum Mol Genet; 2006 Oct; 15 Spec No 2():R182-7. PubMed ID: 16987882
[TBL] [Abstract][Full Text] [Related]
2. The neuropathology of FTD associated With ALS.
Mackenzie IR
Alzheimer Dis Assoc Disord; 2007; 21(4):S44-9. PubMed ID: 18090423
[TBL] [Abstract][Full Text] [Related]
3. [Amyotrophic lateral sclerosis and frontotemporal dementia: overlapping characteristics].
Raaphorst J; Grupstra HF; Linssen WH; van Swieten JC; Schmand B; de Visser M
Ned Tijdschr Geneeskd; 2010; 154():A631. PubMed ID: 20178658
[TBL] [Abstract][Full Text] [Related]
4. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
Wilhelmsen KC; Forman MS; Rosen HJ; Alving LI; Goldman J; Feiger J; Lee JV; Segall SK; Kramer JH; Lomen-Hoerth C; Rankin KP; Johnson J; Feiler HS; Weiner MW; Lee VM; Trojanowski JQ; Miller BL
Arch Neurol; 2004 Mar; 61(3):398-406. PubMed ID: 15023818
[TBL] [Abstract][Full Text] [Related]
5. Frontotemporal lobar degeneration with ubiquitin-positive inclusions: a molecular genetic update.
van der Zee J; Gijselinck I; Pirici D; Kumar-Singh S; Cruts M; Van Broeckhoven C
Neurodegener Dis; 2007; 4(2-3):227-35. PubMed ID: 17596717
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
[TBL] [Abstract][Full Text] [Related]
7. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes.
Schymick JC; Yang Y; Andersen PM; Vonsattel JP; Greenway M; Momeni P; Elder J; Chiò A; Restagno G; Robberecht W; Dahlberg C; Mukherjee O; Goate A; Graff-Radford N; Caselli RJ; Hutton M; Gass J; Cannon A; Rademakers R; Singleton AB; Hardiman O; Rothstein J; Hardy J; Traynor BJ
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):754-6. PubMed ID: 17371905
[TBL] [Abstract][Full Text] [Related]
8. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative diseases. Picking apart the causes of mysterious dementias.
Marx J
Science; 2006 Oct; 314(5796):42-3. PubMed ID: 17023628
[No Abstract] [Full Text] [Related]
10. The molecular basis of frontotemporal dementia.
Neumann M; Tolnay M; Mackenzie IR
Expert Rev Mol Med; 2009 Jul; 11():e23. PubMed ID: 19638255
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
Ugbode C; West RJH
Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
[TBL] [Abstract][Full Text] [Related]
12. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
Fecto F; Siddique T
Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
[TBL] [Abstract][Full Text] [Related]
13. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD.
Münch C; Rosenbohm A; Sperfeld AD; Uttner I; Reske S; Krause BJ; Sedlmeier R; Meyer T; Hanemann CO; Stumm G; Ludolph AC
Ann Neurol; 2005 Nov; 58(5):777-80. PubMed ID: 16240349
[TBL] [Abstract][Full Text] [Related]
15. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
[TBL] [Abstract][Full Text] [Related]
16. Progranulin (PGRN) expression in ALS: an immunohistochemical study.
Irwin D; Lippa CF; Rosso A
J Neurol Sci; 2009 Jan; 276(1-2):9-13. PubMed ID: 18848708
[TBL] [Abstract][Full Text] [Related]
17. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
Ji AL; Zhang X; Chen WW; Huang WJ
J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
[TBL] [Abstract][Full Text] [Related]
18. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Weishaupt JH; Hyman T; Dikic I
Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
[TBL] [Abstract][Full Text] [Related]
19. Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p.
Valdmanis PN; Dupre N; Bouchard JP; Camu W; Salachas F; Meininger V; Strong M; Rouleau GA
Arch Neurol; 2007 Feb; 64(2):240-5. PubMed ID: 17296840
[TBL] [Abstract][Full Text] [Related]
20. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
